Radiation Dose Management Market

Global Radiation Dose Management Market Size (2024 to 2029)

The global radiation dose management market is expected to grow at a CAGR of 14.14% from 2024 to 2029 and will be worth USD 535.06 million by 2029 from USD 276.19 million in 2024.

MARKET DRIVERS

The rising focus on interventional radiology and nuclear medicine is anticipated to promote the growth of the global radiation dose management market.

Increasing interventional radiology and nuclear medicine procedures is one of the factors driving the radiation dose management market forward. The very high dose of radiation in these procedures leads to increased risk in cancer patients. Around 20 million nuclear medicine procedures are performed annually in the U.S., as per the Society of Nuclear Medicine. Key players in the market, such as Bayer Healthcare and Sectra Medical, provide dose management software specifically for RDM in interventional imaging and nuclear medicine. As a result, the applications of interventional radiology and nuclear medicine are predicted to have opportunities in the next five years.

The growing prevalence of cancer is another significant factor boosting the radiation dose management market.

According to the World Health Organization (WHO), low- and middle-income nations account for over 75% of cancer-related deaths.  An increase in cancer cases results in the more significant application of computed tomography (CT) to view the body to detect cancer and radiation therapy, which drives the growth of the radiation dose management market. Radiation dose management software is increasing due to the increasing number of cancer patients. In 2019, 19 million new cancer cases were recorded, an increase of 2 million over 2017, and the deaths were estimated to be around 10 million. The demand for radiation dose management is predicted to increase in the coming years due to the increased number of smokers and tobacco consumers worldwide.

The growing usage of robotic assistance technology is expected to favor the radiation dose management market.

Robotic assistance in radiation therapy is becoming more frequent these days. High-quality multimodal imaging, robotic brachytherapy, and external beam radiation therapy can drive prostate cancer radiation therapy. In addition, a robot-assisted brachytherapy system may enhance the distribution of needles, resulting in better patient care.

In addition, increasing use of medical imaging modalities due to the rising incidence of chronic diseases, raising concerns over radiation dose exposure, growing installation of radiology equipment, rising awareness of radiation dose management, and improved healthcare infrastructure. Furthermore, the increasing spending on healthcare and multi-specialty hospitals and the rising investments by government and private organizations are further anticipated to boost the growth rate of the radiation dose management market.

Advancements in RDM have created opportunities for radiation dose management market players to develop advanced RDM solutions for minimizing the radiation dose emitting from various imaging techniques. Key market players are developing systems with advanced features. In July 2017, Medic Vision announced that the company was granted a patent by the U.S. Patent and Trademark Office on its XR-29 Dose-Check system, which is an integral part of the notable market-leading SafeCT-29 product suiteSafeCT-29 has been Hundreds of medical care centers have installed this safety-29 in medical facilities throughout the U.S. to reduce the radiation dosage automatically in CT scans.

MARKET RESTRAINTS

The absence of standard protocols and lack of funding for radiation dose management are the factors that restrain the growth of the radiation dose management market. In addition, low awareness of radiation dose management systems in emerging nations and the shortage of experienced persons are significant challenges to developing the radiation dose management market.

Impact of COVID-19 on the radiation dose management market

The covid-19 pandemic has had a severe impact on many industries. Coronavirus disease has affected millions of people worldwide, bringing increased focus to the use of radiologic imaging to detect lung abnormalities related to COVID-19. Non-urgent diagnostic imaging surgeries have been postponed due to the pandemic. But radiation dose management has a moderate impact; COVID-19 infection is commonly detected by chest radiography, computed tomography (CT), and ultrasonography. In 2020, the International Atomic Energy Agency (IAEA) held a survey to discuss CT practice and protocol optimization for COVID-19 pneumonia about the use of CT and associated radiation doses on patients with a COVID-19 infection.

REPORT COVERAGE

SEGMENTAL ANALYSIS 

Global Radiation Dose Management Market Analysis By Product and Services

Based on the products & services, the radiation dose management solutions segment held the largest share of the radiation dose management market worldwide in 2021. The segment's growth is due to healthcare providers' growing adoption of radiation dose management solutions because of increased international regulations on radiation exposure.

Global Radiation Dose Management Market Analysis By Technology

The CT segment occupied the largest share of the global radiation dose management market in 2024, owing to the increased application of computed tomography (CT) to identify cancer in the body. As a result, radiation exposure has been growing in patients who have undergone tomography. The hazard of radiation exposure to patients is minimized with advanced CT equipment with features like dose reduction hardware and software-embedded technology.

Global Radiation Dose Management Market Analysis By Application

Based on the application, the oncology segment led the radiation dose management market in 2024. This is due to increasing cancer cases worldwide, resulting in the application of computed tomography (CT) and subsequent radiation therapy.

Global Radiation Dose Management Market Analysis By End-User

Based on the end-user, the hospital segment accounted for a significant share of the radiation dose management market in 2022, owing to the rising patient population, growing awareness about the benefits of early disease diagnosis, technological advancements in imaging modalities, and the increasing awareness of the harmful effects of radiation exposure, increase in numbers of diagnostic procedures done in the hospitals for the treatment and management of several diseases. 

REGIONAL ANALYSIS 

The North American region accounted for the leading share of the radiation dose management market worldwide in 2022. The growth of this region is due to the stringent legislative and accreditation requirements regarding the reporting and optimization of radiation doses, the high adoption of HCIT technologies, and the presence of strict regulatory requirements regarding patient safety, the growing count of patients, and the heightening utilization of technology increasing incidences of chronic ailments such as cancer requiring radiation dose and computed tomography.

Europe was the second largest regional market in the worldwide radiation dose management market in 2022 due to a government initiative to upsurge patient safety, the occurrence of chronic diseases, expanding healthcare expenditure, and rising awareness about radiation dose safety through campaigns and conferences are the drives for the radiation dose management market growth in the region. 

Asia-Pacific region is expected to have market share due growing population, increased awareness and application of radiation therapy in hospitals and diagnostic centers, and the heightening utilization of technology in India, driving the growth of the Radiation Dose Management Market in the Asia-Pacific region. 

KEY PLAYERS IN THE GLOBAL RADIATION DOSE MANAGEMENT MARKET

Bayer AG, Mckesson Corporation, AGFA Healthcare, GE Healthcare Ltd., Sectra Medical Systems GmbH, Fujifilm Holdings Corporation, PACS Health LLC, Koninklijke Philips N.V., Siemens Healthcare Diagnostics Inc., Novarad Corporation, and Toshiba Medical Systems Corporation are some of the notable players operating in the radiation dose management market.

RECENT HAPPENINGS IN THIS MARKET

• In 2021, Affidea launched GE's latest radiation dose management software. It helps centers personalize dosing, strengthen clinical protocols, reduce the risk of unnecessary dosing, and improve tracking of adverse events.
• In 2020, Bayer Radiology Announced the Transformation of Radiometric. As a result, patient-care teams may report, track, and manage radiation doses with the help of Radimetrics 3.0.

DETAILED SEGMENTATION OF THE GLOBAL RADIATION DOSE MANAGEMENT MARKET INCLUDED IN THIS REPORT

This research report on the global radiation dose management market has been segmented and sub-segmented into the products & services, modality, application, end-user, and region.

By Product and Services

• Radiation Dose Management Solutions 
  • Standalone Solutions
  • Integrated Solutions
• Radiation Dose Management Services
  • Support & Maintenance Services
  • Implementation & Integration Services
  • Consulting Services
  • Education & Training Services

By Technology:

• Computed Tomography 
• Fluoroscopy & Interventional Imaging 
• Radiography & Mammography
• Nuclear Medicine

By Application

• Oncology
• Cardiology
• Orthopedic Applications
• Other Application

By End-User

• Hospitals 
• Small Hospitals
• Large Hospitals
• Ambulatory Care Settings
• Other End Users

By Region

• North America
• Europe
• Asia-Pacific
• Middle East Africa
• Latin America